The stock of HealthEquity Inc. (NASDAQ:HQY) increased by $1.44 on Friday to finish at $68.15, up 2.16 percent. The last five days have seen an average of 517,200 shares of common stock traded. 9 times new highs were reached in the current year, with a gain of $6.51. The average number of shares traded over the last 20 days was 493,390, while the average volume over the last 50 days totaled 565,482.
HQY stock appreciated 7.51% since last month. On 07/26/23, the company’s shares reached a one-month low of $61.50. The stock touched a high of $79.20 on 08/03/23, after rallying from a low of $48.86 in 52 weeks. The price of HQY stock has risen by 10.56% or $6.51 this year, reaching a new high 9 times. Still, the stock price is down -13.95% from the 52-week high.
Insider Transactions
HQY stock investors should be aware that HealthEquity Inc. (HQY) stock had its last reported insider trading activity 62 days ago on Jun 27. On Jun 27, PRESIDENT AND CEO Kessler Jon sold 27,230 shares at $60.96 each. This transaction resulted in the insider making $1,659,996. On Jun 26, Kessler Jon sold 19,588 shares at a price of US$60.12. After the transaction, the insider now owns 6,129 shares. EVP, CHIEF TECHNOLOGY OFFICER Rosner Elimelech had earlier sold 10,156 shares on Jun 12 for $64.29 a share. The transaction was completed for $652,925.
Valuation Metrics
Beta for the stock is 0.79. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 6.33, the price-to-book (PB) ratio of 3.02, and the price-to-cash flow ratio of 47.12.
Financial Health
For the three months ended April 29, HealthEquity Inc.’s quick ratio was 4.00, while its current ratio was 4.00, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending April 29 is 0.45, and the total debt to equity ratio is 0.45. As far as profitability goes, gross margin for the trailing twelve months is 58.50% percent. HealthEquity Inc.’s EBITDA margin for the year ended April 29 was 23.08%, whereas its operating margin stood at 4.20% for the same period. Based on annual data, it had gross profit of $490.09 million and revenue of $861.75 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. HQY’s return on assets (ROA) during the last 12 months has been -0.30%. There was a 0.70% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -0.40%.
Earnings Surprise
According to HealthEquity Inc.’s quarterly financial report for the quarter that ended April 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $244.43 million, while revenues rose by 15.85% to $128.65 million. It was predicted that HealthEquity Inc.’s quarterly earnings would be $0.5, but it ended up being $0.41, beating the consensus by 22.00%. EBITDA was $63.0 million for the quarter. At the end of HealthEquity Inc.’s most recent quarter ended April 29, its liabilities totaled 1.12 billion, while its total debt was $942.17 million. Equity owned by shareholders amounts to $85.47 million.
Technical Picture
Here’s a quick look at HealthEquity Inc.’s (HQY) price momentum from a technical perspective. As of 25 August, the RSI 9-day stood at 53.85%, suggesting the stock is Neutral, with a 32.38% historical volatility rate.
The stochastic %K and %D were 44.61% and 47.08% respectively, while the average true range (ATR) was 2.17. Based on the 14-day stochastic reading of 59.64%, the RSI (14) reading is 54.41%. On the 9-day MACD Oscillator, the stock is at -0.47, and the 14-day reading is at -0.47.
Analyst Ratings
In its most recent analyst report, Goldman raised its rating on HealthEquity Inc. (NASDAQ: HQY) to a Neutral. Prior to this, analysts firm rated the stock as a Sell. Analysts have assigned HealthEquity Inc. (HQY) an Buy rating. HQY is a stock that is recommended for selling by 0 brokerage firms, while 1 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 1 rate it overweight and 11 others recommend it as a buy.
What is HQY’s price target for the next 12 months?
The current consensus forecast for the stock is between $71.00 and $94.00, with a median target price of $81.00. In analyzing these forecasts, the average price target given by analysts for HealthEquity Inc. (HQY) is $81.77.
